Frequency of Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) and Estimated Incidence Rates of Post-PTSMA Cardiovascular Outcomes: A Descriptive Analysis

Basic Details
Date Posted
Tuesday, September 15, 2020
Health Outcome(s)
percutaneous transluminal septal myocardial ablation

The goal of this request was to identify and count percutaneous transluminal septal myocardial ablation (PTSMA) procedures, and estimate incidence rates of post-PTSMA cardiovascular outcomes in the Sentinel Distributed Database (SDD). Only aggregate level data was returned. Two runs of the program were required.

The study period included data from June 1, 2014 to June 21, 2018. We distributed this request to 16 Data Partners on October 28, 2019.

Additional Details
FDA Center
Time Period
June 1, 2014 - June 21, 2018
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
Individuals 18 years of age and older
Data Sources
Sentinel Distributed Database (SDD)